Hyperfine, Inc. (HYPR) DCF Valuation
- ✓ Entièrement Modifiable: Adapté À Vos Besoins Dans Excel Ou Sheets
- ✓ Conception Professionnelle: Modèles Fiables Et Conformes Aux Normes Du Secteur
- ✓ Pré-Construits Pour Une Utilisation Rapide Et Efficace
- ✓ Aucune Expertise N'Est Requise; Facile À Suivre
Hyperfine, Inc. (HYPR) Bundle
Enhance your investment choices with the Hyperfine, Inc. (HYPR) DCF Calculator! Explore real Hyperfine financials, adjust growth projections and expenses, and observe how these modifications affect the intrinsic value of Hyperfine, Inc. (HYPR) in real-time.
Discounted Cash Flow (DCF) - (USD MM)
Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
---|---|---|---|---|---|---|---|---|---|---|
Revenue | .0 | .3 | 1.5 | 6.8 | 11.0 | 18.3 | 30.2 | 50.0 | 82.7 | 136.9 |
Revenue Growth, % | 0 | 0 | 408.84 | 355.48 | 61.9 | 65.48 | 65.48 | 65.48 | 65.48 | 65.48 |
EBITDA | -19.8 | -23.2 | -64.1 | -72.9 | -47.1 | -11.0 | -18.1 | -30.0 | -49.6 | -82.1 |
EBITDA, % | 100 | -7891.84 | -4287.57 | -1069.25 | -426.59 | -60 | -60 | -60 | -60 | -60 |
Depreciation | .1 | .3 | .7 | 1.0 | 1.1 | 9.9 | 16.4 | 27.1 | 44.9 | 74.3 |
Depreciation, % | 100 | 98.3 | 48.53 | 14.9 | 9.55 | 54.26 | 54.26 | 54.26 | 54.26 | 54.26 |
EBIT | -20.0 | -23.5 | -64.9 | -73.9 | -48.1 | -11.0 | -18.1 | -30.0 | -49.6 | -82.1 |
EBIT, % | 100 | -7990.14 | -4336.1 | -1084.15 | -436.14 | -60 | -60 | -60 | -60 | -60 |
Total Cash | 26.4 | 62.7 | 188.5 | 117.5 | 75.2 | 18.3 | 30.2 | 50.0 | 82.7 | 136.9 |
Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
Account Receivables | .0 | .2 | .6 | 2.6 | 4.1 | 10.1 | 16.7 | 27.7 | 45.9 | 75.9 |
Account Receivables, % | 100 | 59.18 | 43.05 | 37.53 | 37.45 | 55.44 | 55.44 | 55.44 | 55.44 | 55.44 |
Inventories | .0 | 1.7 | 4.3 | 4.6 | 6.6 | 15.6 | 25.8 | 42.7 | 70.7 | 117.0 |
Inventories, % | 100 | 584.35 | 288.1 | 67.83 | 59.66 | 85.5 | 85.5 | 85.5 | 85.5 | 85.5 |
Accounts Payable | 1.2 | .9 | 2.2 | .7 | 1.2 | 11.7 | 19.4 | 32.1 | 53.1 | 87.9 |
Accounts Payable, % | 100 | 322.45 | 150.27 | 9.95 | 11 | 64.19 | 64.19 | 64.19 | 64.19 | 64.19 |
Capital Expenditure | -.2 | -1.6 | -2.7 | -.6 | -.8 | -7.9 | -13.0 | -21.6 | -35.7 | -59.1 |
Capital Expenditure, % | 100 | -533.33 | -181.22 | -8.59 | -7.29 | -43.17 | -43.17 | -43.17 | -43.17 | -43.17 |
Tax Rate, % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EBITAT | -19.3 | -23.4 | -64.8 | -73.2 | -48.1 | -10.9 | -18.0 | -29.7 | -49.2 | -81.4 |
Depreciation | ||||||||||
Changes in Account Receivables | ||||||||||
Changes in Inventories | ||||||||||
Changes in Accounts Payable | ||||||||||
Capital Expenditure | ||||||||||
UFCF | -18.2 | -26.8 | -68.6 | -76.5 | -50.9 | -13.3 | -23.8 | -39.4 | -65.1 | -107.8 |
WACC, % | 8.42 | 8.42 | 8.42 | 8.42 | 8.42 | 8.42 | 8.42 | 8.42 | 8.42 | 8.42 |
PV UFCF | ||||||||||
SUM PV UFCF | -182.5 | |||||||||
Long Term Growth Rate, % | 2.00 | |||||||||
Free cash flow (T + 1) | -110 | |||||||||
Terminal Value | -1,712 | |||||||||
Present Terminal Value | -1,143 | |||||||||
Enterprise Value | -1,325 | |||||||||
Net Debt | -75 | |||||||||
Equity Value | -1,250 | |||||||||
Diluted Shares Outstanding, MM | 71 | |||||||||
Equity Value Per Share | -17.53 |
What You Will Get
- Real HYPR Financial Data: Pre-filled with Hyperfine’s historical and projected data for precise analysis.
- Fully Editable Template: Modify key inputs like revenue growth, WACC, and EBITDA % with ease.
- Automatic Calculations: See Hyperfine’s intrinsic value update instantly based on your changes.
- Professional Valuation Tool: Designed for investors, analysts, and consultants seeking accurate DCF results.
- User-Friendly Design: Simple structure and clear instructions for all experience levels.
Key Features
- Customizable Financial Inputs: Adjust essential variables such as revenue projections, profit margins, and investment costs.
- Instant DCF Valuation: Automatically computes intrinsic value, net present value (NPV), and additional financial metrics.
- High-Precision Accuracy: Leverages Hyperfine's actual financial data for precise valuation results.
- Effortless Scenario Testing: Easily explore various assumptions and analyze different outcomes.
- Efficiency Booster: Streamline your workflow by avoiding the complexities of creating detailed valuation models from the ground up.
How It Works
- Step 1: Download the Excel file.
- Step 2: Review pre-entered Hyperfine, Inc. (HYPR) data (historical and projected).
- Step 3: Adjust key assumptions (yellow cells) based on your analysis.
- Step 4: View automatic recalculations for Hyperfine, Inc. (HYPR)’s intrinsic value.
- Step 5: Use the outputs for investment decisions or reporting.
Why Choose This Calculator?
- Designed for Experts: A sophisticated tool tailored for analysts, CFOs, and industry consultants.
- Accurate Data: Hyperfine, Inc.’s (HYPR) historical and projected financials are preloaded for precision.
- Flexible Scenario Analysis: Effortlessly simulate various forecasts and assumptions.
- Comprehensive Outputs: Automatically computes intrinsic value, NPV, and essential metrics.
- User-Friendly: Clear, step-by-step instructions help you navigate the process with ease.
Who Should Use Hyperfine, Inc. (HYPR)?
- Healthcare Professionals: Leverage advanced imaging technology to enhance patient care.
- Medical Researchers: Utilize innovative tools for groundbreaking studies and trials.
- Investors: Analyze market potential and growth opportunities in the healthcare sector.
- Educators and Students: Explore practical applications of medical imaging in academic settings.
- Regulatory Bodies: Ensure compliance and safety standards in medical technology.
What the Template Contains
- Pre-Filled DCF Model: Hyperfine, Inc.’s financial data preloaded for immediate use.
- WACC Calculator: Detailed calculations for Weighted Average Cost of Capital.
- Financial Ratios: Evaluate Hyperfine, Inc.’s profitability, leverage, and efficiency.
- Editable Inputs: Change assumptions such as growth, margins, and CAPEX to fit your scenarios.
- Financial Statements: Annual and quarterly reports to support detailed analysis.
- Interactive Dashboard: Easily visualize key valuation metrics and results.